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Sea-Level Assessment of Dynamic Cerebral Autoregulation
Predicts Susceptibility to Acute Mountain Sickness at
High Altitude
Nicholas J. Cochand, MD*; Michael Wild, MD*; Julien V. Brugniaux, PhD*; Peter J. Davies, MD, FRCP;
Kevin A. Evans, PhD; Richard G. Wise, PhD; Damian M. Bailey, PhD, FPVRI, FRSC, FACSM*
Background and Purpose—Dynamic cerebral autoregulation is impaired in subjects who develop acute mountain sickness
(AMS), a neurological disorder characterized by headache. The present study examined if the normoxic sea-level
measurement of dynamic cerebral autoregulation would predict subsequent susceptibility to AMS during rapid ascent
to terrestrial high altitude.
Methods—A dynamic cerebral autoregulation index was determined in 18 subjects at sea level from continuous recordings
of middle cerebral artery blood flow velocity (Doppler ultrasonography) and arterial blood pressure (finger
photoplethysmography) after recovery from transiently induced hypotension. Six hours after passive ascent to 3800 m
(Mt Elbrus, Russia), the Lake Louise and Environmental Symptoms Cerebral Symptoms questionnaires were used to
assess AMS.
Results—AMS scores increased markedly at high-altitude (Lake Louise: 32 points, P0.001 and Environmental
Symptoms Cerebral Symptoms: 0.60.9 points, P0.0003 versus sea level). Inverse relationships were observed
between the sea-level autoregulation index score and the high-altitude-induced increases in the Lake Louise (r0.62,
P0.007) and Environmental Symptoms Cerebral Symptoms (r0.78, P0.01) scores. One subject with a history of
high-altitude pulmonary and cerebral edema presented with the lowest sea-level autoregulation index score (3.7 versus
group: 6.21.0 points) and later developed high-altitude cerebral edema at 4800 m during the summit bid.
Conclusions—These findings suggest that a lower baseline autoregulation index may be considered a potential risk factor
for AMS. This laboratory measurement may prove a useful screening tool for the expedition doctor when considering
targeted pharmacological prophylaxis in individuals deemed “AMS-susceptible.” (Stroke. 2011;42:3628-3630.)
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Acute mountain sickness (AMS) is a neurological disordercharacterized by headache that is typically encountered by
mountaineers after rapid ascent to high altitude. Current opinion,
albeit controversial,1 suggests that AMS is a mild form of
high-altitude cerebral edema and that both syndromes share a
common pathophysiology linked by vasogenic edematous brain
swelling and intracranial hypertension.2
Recently, dynamic cerebral autoregulation was shown to
be impaired during acute hypoxia3 and in direct proportion to
AMS symptom scores4 suggesting it may represent a poten-
tial risk factor. However, the link between impaired dynamic
cerebral autoregulation and symptomatology is not a univer-
sal finding3 and warrants further clarification. Thus, in the
present study, we have adopted an alternative approach by
examining if the biological variation in dynamic cerebral
autoregulation observed in the “healthy brain” at sea level
would predict subsequent susceptibility to AMS during a
rapid ascent to terrestrial high altitude.
Materials and Methods
Subjects and Design
After ethics approval, 18 subjects (13 male/5 female) aged 29
(mean)9 (SD) years were recruited as part of a medical research
expedition to Mt Elbrus (5740 m) in Russia. Five (male) had a
history of severe AMS (AMS) and of these, 1 had documented
high-altitude pulmonary edema confirmed by chest radiography and
1 had 2 separate incidences of combined high-altitude pulmonary
edema and high-altitude cerebral edema. All remaining subjects were
altitude-naïve (AMS). Measurements were performed at sea level
72 days before departure for Russia and 6 hours after passive
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ascent to 3800 m by cable car. Oral prophylaxis against AMS was
avoided.
Dynamic Cerebral Autoregulation
Mean Arterial Pressure
Beat-to-beat arterial pressure waveforms were recorded continuously
by finger photoplethysmography (Finometer PRO; Finapres Medical
Systems, Amsterdam, The Netherlands).
Middle Cerebral Artery Velocity
The right middle cerebral artery was insonated with a 2-MHz pulsed
transcranial Doppler ultrasound (Multi-Dop X4; DWL Elektroniche
Systeme GmbH, Germany) and secured with an adjustable headset.
Autoregulatory Index
This was determined using the thigh cuff inflation–deflation tech-
nique.5 Briefly, bilateral thigh cuffs were connected to a Hokanson
E20 (Bellevue, WA) and inflated to 30 mm Hg above the recorded
systolic blood pressure for 3 minutes. Lower-limb ischemia was
confirmed using Doppler by a lack of blood flow in the dorsalis pedis
artery. Cuffs were subsequently deflated (0.1 second) and the
process repeated 3 times with a 8-minute intertrial recovery period.
An autoregulatory index was assigned to each of the trials after
computation of a second-order linear differential equation6 and
ranged between 0 arbitrary units (entirely passive autoregulation)
and 9 (most brisk autoregulation). The mean (autoregulatory index)
value of the 3 trials was determined and used in subsequent analyzes
as the index of dynamic cerebral autoregulation.
Acute Mountain Sickness
The Lake Louise and Environmental Symptoms Questionnaire Cerebral
scoring systems were used to assess AMS as previously described.7
Statistical Analysis
Given the small sample size, data were analyzed using nonparamet-
ric statistics. Changes from sea level to high altitude and differences
between AMS versus AMS were analyzed using Wilcoxon
matched pairs signed ranks and Mann Whitney U tests, respectively.
The relationship between sea-level autoregulatory index scores and
AMS scores were examined using a Spearman rank correlation
coefficient. Significance was established at P0.05.
Results
Thigh-cuff deflation during the assessment of dynamic cere-
bral autoregulation resulted in an average (of 3 separate trials)
dynamic reduction (taken as the nadir) in mean arterial
pressure of 225 mm Hg (range, 19–26 mm Hg) relative to
the baseline observed during the period of cuff inflation
(P0.0002). AMS scores increased from 00 (Lake Louise)
and 0.00.0 points (Environmental Symptoms Question-
naires Cerebral Symptoms) points at sea level to 32 and
0.60.9 points at high altitude (P0.001 and P0.0003,
respectively). The autoregulatory index scores were compa-
rable (P0.12) between AMS (5.51.1 arbitrary units) and
AMS (6.40.9 arbitrary units). In contrast, the Figure
illustrates the inverse relationships observed between the
sea-level autoregulatory index score and the respective in-
creases in Lake Louise (Figure A) and Environmental Symp-
toms Questionnaires Cerebral Symptoms (Figure B) scores.
The subject with the combined history of high-altitude
pulmonary edema and high-altitude cerebral edema presented
with the lowest sea-level autoregulatory index score (3.7
arbitrary units versus group: 6.21.0 arbitrary units) and
subsequently developed high-altitude cerebral edema (truncal
ataxia and clouded consciousness) at 4800 m during the
summit bid.
Discussion
The major novel finding in the present study is that a lower
baseline (sea-level) autoregulatory index score may prove a
potential risk factor for AMS during subsequent ascent to
high altitude, accounting for up to 60% of the observed
variance. These subtle imperfections in dynamic cerebral
autoregulation, detectable in the healthy brain as part of
normal biological variation, indicate that the “AMS-
susceptible” individual may be less capable of buffering rapid
surges in mean arterial pressure and, consistent with the
traditional paradigm,2 inherently more vulnerable to vaso-
genic edematous brain swelling and intracranial hypertension
at high altitude.
The observation that dynamic cerebral autoregulation be-
comes impaired during hypoxia corroborates diffusion-
weighted MRI evidence for mild vasogenic brain swelling of
the corpus callosum.8 Thus, disordered cerebral autoregula-
tion has the capacity to disrupt the blood–brain barrier and
cause mild hyperperfusion.9 However, the link to symptom-
atology remains more tenuous given the failed attempts to
detect any “additional” vasogenic brain swelling or intracra-
nial hypertension in AMS. Furthermore, why such a minor
shift of water into the corpus callosum should trigger the
cephalalgia of AMS remains an added complication.
However, the inverse relationships observed in the present
study between sea-level autoregulatory index and AMS
symptom scores did not occur by “chance alone,” thus forcing
a reappraisal of the previous interpretation that impaired
dynamic cerebral autoregulation is simply an incidental
finding.4,10 However, we recognize that the small sample size
used in the present study and corresponding constraints
Figure. Inverse relationships observed between the baseline autoregulatory index (in arbitrary units [AU]) taken as the mean value
obtained from 3 trials recorded at sea level and increase in the Lake Louise (LL: A) and Environmental Symptoms Questionnaires Cere-
bral Symptoms (ESQ-C: B) scores at 3800 m (Mt Elbrus, Russia).
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imposed on statistical power may limit generalization to the
wider community of mountain climbers who are at risk of
developing AMS. Furthermore, the assessment of dynamic
cerebral autoregulation using the thigh cuff inflation–defla-
tion technique has, like other methods,11 inherent limitations,
the most notable being assessment of the brain’s cerebral
autoregulation response to a hypotensive as opposed to a
hypertensive challenge, the latter being more appropriate
given the proposed link to intracranial hypertension. Future
studies need to consider transfer function analysis of sinusoi-
dal mean arterial pressure oscillations “forced” through re-
peated squat–stand or lower body negative pressure maneu-
vers to more reliably engage cerebral autoregulation given
that there is evidence to suggest that cerebral autoregulation
is more effective at dealing with an increase (as opposed to a
decrease) in mean arterial pressure.12 These improved meth-
ods that have yet to be applied in the setting of AMS
combined with serial diffusion-weighted MRI measurements
will provide clearer insight into the underlying mechanisms.
Given the insidious nature of AMS and its prevalence
during commercial expeditions,2 early recognition of “sus-
ceptible individuals” through the measurement of dynamic
cerebral autoregulation at sea level may provide a useful
screening tool for the expedition doctor who may want to
consider targeted pharmacological prophylaxis and thus pre-
vent further neurological complications at high altitude.
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